We are buying TSPT (NASDAQ), pending FDA approval for its drug Intermezzo and yesterday partenership annocement:

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

SPPI (NASDAQ) up 7% to 7,2 usd


We are buying SQNM (NASDAQ) today at open before earning release on thursday
We are buying ARNA (NASDAQ) before earnings call tonight, pending clinical data 
We are selling VNDA (NASDAQ) for second time with 25% gain

TICKER            BUY AREA    QUOTE NOW     POSITION            DRIVER

ARNA (NASDAQ)  USD 5,05                  SHORT TERM     PENDING SEPTEMBER CLINICAL DATA
SQNM (NASDAQ) USD 5,85            5,9     SHORT TERM EARNING RELEASE AND PRODUCT UPDATE
TSPT (NASDAQ)  USD 7,8            8,2         LT INTERMEZZO PENDING FDA APPROVAL-PARTNERSHIP
ALXA (NASDAQ)  USD 2,28             2,6             LT       STRONG CONSENSUS
CYTK (NASDAQ) USD 3                   3,05             LT    STRONG CONSENSUS  PENDING CLINICAL DATA
ARIA (NASDAQ) USD 2,35           1,90 SOLD (-19%)
AEZS(NASDAQ)  USD 2,1            2,55            LT       STRONG CONSENSUS, PENDING DATA
JAV (AMEX)  USD 1,3               1,85                        STRONG CONSENSUS
NPSP (NASDAQ)      USD 4,7                  4               LT                STRONG CONSENSUS
ONXX(NASDAQ)       USD 35,9              36,1             LT                      NEXAVAR
IDIX (NASDAQ)        USD  4,44            4,2 SOLD(-5%)

SNTS (NASDAQ)     USD   2,81          3,25 SOLD(+17%)  

BFRM (NASDAQ)        USD   2,85          2,55             LONG TERM

OCLS (NASDAQ) USD 2,85      2,45 SOLD (-15%)                                

TRGT (NASDAQ) USD 5,5          8,7 SOLD(+60%) 

OREX (NASDAQ) USD 5,35     6,45 SOLD(+20%)  

FOLD (NASADQ) USD 10           11  LONG TERM     PLICERA, AMIGAL STRONG  CONSENSUS

SOMX (NASDAQ) USD 1,10       1,38   SOLD (+25%)    

DDSS (NASDAQ)  USD 2,65    1,9    HOLD  TRAZODONE manifacturing issue 7/24/09

XNPT (NASDAQ)  USD 21,85      20,7   LONG TERM    XP19986  POSITIVE TRIAL 6/30/09

VNDA (NASDAQ) 12,1                 15,2SOLD (+25%)       

CYTR (NASDAQ)   USD 1,02      1,02       LONG TERM    STRONG  CONSENSUS

JAZZ (NASDAQ)    USD 4,95     7,3 SOLD (+45%)  

PARD (NASDAQ)    USD 5          5,9      PROFIT TAKING(+18%)     

PARD (NASDAQ) USD 6,6 rebought 7/2    7,2  LONG TERM       STRONG CONSENSUS

INCY (NASDAQ) USD 3,5         5,2 SOLD (+50%)   

ISTA (NASDAQ) USD 4,1      5,1 LONG TERM          BEPREVE  FDA  PDUFA  9/12/09

SLXP (NASDAQ) USD 9,9       12,1  LONG TERM  STRONG CONSENSUS FDA  PDUFA 9/9/09

MAPP (NASDAQ) USD 11,3       10,1  REBUYING LONG TERM STRONG CONSENSUS 

ARYX (NASDAQ) USD            4,5       SOLD 2,5 (-45%)

GTXI (NASDAQ)   USD 9,5     10,2    LONG TERM         FDA  PDUFA 10/30/09

UTHR (NASDAQ) USD 84         96 SOLD (+15%) 

NGSX (NASDAQ) USD 6,4      8,2 SOLD(+30%)

VICL (NASDAQ)  USD 3         3,8 PRE-MKT.   LONG TERM      SWINE FLU

STAA (NASDAQ)  USD 3,3        2,7  LONG TERM   FDA CLEARENCE FOR Epiphany(TM)

ALTH (NASDAQ)  7,9              7,9   LONG TERM          FDA PDUFA 9/24/09

AMAG (NASDAQ) 52,8        44  LONG TERM        FDA APPROVES FERAHEME 6/30/09

XOMA (NASDAQ) 1,2    0,78  LONG TERM  OVERSOLD

HEB (AMEX)    3,3(5%OF CAPITAL)  2,25 SOLD(-35%)                                

HEB (AMEX) was rebought after 100% gain (see old posts)

MRNA (NASDAQ)  3,3            1,4 SOLD (-55%)    

RIGL (NASDAQ) USD 10           10,1 SOLD  FLAT

MITI (NASDAQ) USD 6              6,3       LONG TERM      OVERSOLD

MNKD (NASDAQ) USD 8,3         7,95    SOLD(-4%)    

SVNT (NASDAQ) USD 7,10        13       SOLD(+90%)

NPSP (NASDAQ) 3,1 USD        4,75     SOLD(+50%)

SCLN (NASDAQ) 2,25 USD        2,7     SOLD (+20%)  LONG TERM ZADAXIN SALES

MAPP (NASDAQ) 8 USD  (posts from 5/26)  PROFIT TAKED(+45%)   LEVADEX

VNDA (NASDAQ) 8 USD (see old post 5/8)  PROFIT TAKED(+80%)     FANAT

CLDA (NASDAQ) 15,7 USD       15  LONG TERM   OVERSOLD

CTIC (NASDAQ) 2,10 USD        1,39 SOLD (-35%)

ANPI (NASDAQ) 2 USD           1,39 SOLD(-30%)

MEDX (NASDAQ) 7,5 USD   8,7  PROFIT TAKING(+20%)  LTERM RECENT PRODUCTS RESULTS

MNTA (NASDAQ) 8,9 USD      11  LONG TERM   STRONG CONSENSUS

ACAD (NASDAQ) 2,6 USD     5 SOLD (+95%)   

ACOR (NASDAQ) 24 USD    26  LONG TERM FAMPRIDINE-SR, FDA PDUFA 10/22/09

BDSI (NASDAQ)                           PROFIT TAKED 6,3  (+18%)  

BDSI (NASDAQ)  6,6 rebought   5,75      SHORT TERM    ONSOLIS APPROVED BY FDA

DNDN (NASDAQ)  22 USD (see old post 4/27) 24,6  LONG TERM  PROVENGE

SPPI (NASDAQ)  4 USD (see ols post 5/12)    6/12  PROFIT TAKING (+35%)

SPPI (NASDAQ)  5,85 USD         7,4      PROFIT TAKING(+28%) 

SPPI (NASDAQ)  6,5 USD rebought 7/2  7,2 LT  ZEVALIN FDA PDUFA  09/07/09

FUSILEV PDUFA 08/10/09